Hormone therapy when cardiovascular risk is in the picture

Menopausal hormone therapy can still be considered in selected women with cardiovascular risk factors, but timing, route, and formulation matter. The discussion here covers starting closer to the time of menopause, preferring transdermal oestradiol with appropriate progesterone when needed, and working alongside heart-healthy habits and risk assessment to individualise care.